Cargando…
A Human Neural Crest Stem Cell-Derived Dopaminergic Neuronal Model Recapitulates Biochemical Abnormalities in GBA1 Mutation Carriers
Numerically the most important risk factor for the development of Parkinson's disease (PD) is the presence of mutations in the glucocerebrosidase GBA1 gene. In vitro and in vivo studies show that GBA1 mutations reduce glucocerebrosidase (GCase) activity and are associated with increased α-synuc...
Autores principales: | Yang, Shi-Yu, Beavan, Michelle, Chau, Kai-Yin, Taanman, Jan-Willem, Schapira, Anthony H.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355624/ https://www.ncbi.nlm.nih.gov/pubmed/28216145 http://dx.doi.org/10.1016/j.stemcr.2017.01.011 |
Ejemplares similares
-
Evolution and clustering of prodromal parkinsonian features in GBA1 carriers
por: Mullin, Stephen, et al.
Publicado: (2019) -
Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson’s Disease
por: Grigor’eva, Elena V., et al.
Publicado: (2023) -
Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
por: Sanchez-Martinez, Alvaro, et al.
Publicado: (2016) -
Ambroxol reverses tau and α-synuclein accumulation in a cholinergic N370S GBA1 mutation model
por: Yang, Shi Yu, et al.
Publicado: (2022) -
Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease
por: Mullin, Stephen, et al.
Publicado: (2020)